Forest Expands Gastrointestinal Portfolio with up to US$1.46 B Furiex Purchase
By Heather Cartwright
Pharma Deals Review: Vol 2014 Issue 5 (Table of Contents)
Published: 23 May-2014
DOI: 10.3833/pdr.v2014.i5.2030 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Forest Laboratories, which is in the process of being acquired by Actavis, has agreed to buy Furiex Pharmaceuticals for US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS